Are umbilical cord stem cells safe? What the research says

Where do these cells actually come from?

After a healthy birth, the umbilical cord is usually thrown away. Inside it is a soft, gel-like tissue called Wharton’s jelly, and that jelly is rich in mesenchymal stem cells, or MSCs.

That is the only source Stem Cells Colombia uses. Not cord blood, not bone marrow, not fat. No embryo is involved, and nobody has a needle put into their hip bone to collect anything.

Every cord starts with a Colombian donor chosen through an exhaustive selection process. She and her family are screened to confirm that she is free of viruses, bacteria, infections and disease, and more tests are done after the cord is collected. Every batch the clinic receives comes with, besides the quality certificate, a checklist and release document that lists which tests were done and their results.

And you receive a quality certificate for each vial used in your treatment.

Think of the cord as a newborn’s first packed lunch: made for a big job, and full of young, busy cells.

So, are they safe?

This is the question with the clearest answer. In 2020, researchers pooled 55 randomized trials with more than 2,600 patients who received MSCs into a vein. The only side effect that showed up more often than in the comparison groups was a temporary fever.

In 2026, the same kind of review looked only at umbilical cord MSCs: 42 randomized trials, about 2,280 patients. Again, fever was more common; infections, blood clots and deaths were not, and no trial had to stop early for safety.

After a joint or spine application, you rest at the hotel, one elevator away, with your coordinator checking on you. And every IV protocol starts with cancer markers, for your safety.

Why doesn’t my body reject someone else’s cells?

MSCs carry very few of the “ID badges” your immune system checks before it attacks something foreign. That is why trials routinely use them from unrelated donors, with no matching and no anti-rejection drugs.

A review in Tissue Engineering went further: compared with MSCs from adult tissues, cord MSCs looked more primitive, multiplied faster and had stronger calming effects on the immune system. That lab comparison helps explain why cord tissue became a favorite source.

Then do they work?

In short: it depends on what you want them to work for. MSCs are studied for dozens of conditions, and research is growing for each of them.

Knee osteoarthritis is one of the better-studied uses. In a randomized trial in Chile, patients who received cord MSCs twice had less pain at one year than patients who received hyaluronic acid, a common knee injection. It is one of several trials that keep building the evidence.

That is the pattern across the field: promising, measurable and growing. A specialist reviews what the studies show for your condition.

How do you tell a careful clinic from a careless one?

• Ask what the cells are and where they come from. The answer should be one clear sentence.
• Ask who applies them, and whether it is done with imaging guidance in an operating room.
• Ask how they review your case. A good team talks about “may” and “could,” and a specialist reviews your case first, so your plan is designed for you.